Harry Boxer
The Technical Trader
The stock market indices started out the week with a little pullback, and then a pop to the upside immediately, but that failed at resistance. They pulled back one more time and made slightly lower lows, and held support. That was significant because the markets put on a 5-wave advance over the next several hours to reach 4430 Nasdaq 100 and 2054 S&P 500, which were new highs for the rally. They then pulled back with an hour and a half to go, and in the last half hour they bounced again to finish positive on the day.
Net on the day, the Dow was up 21.57 at 17,623.87. The S&P 500 was up 2.02 to 2051.60, 8 off the low. The Nasdaq 100 was up 16.15 to 4426.98, 27 points off the low.
Advance-declines were negative all day but managed to go in the positive column by just a few issues on the New York Stock Exchange, and 80 issues on Nasdaq. Up/down volume was 17 to 15 positive on New York, total volume of 3 1/3 billion shares traded. The Nasdaq traded 1.58 billion shares and had an 80 to 78 positive volume ratio.
It was a modestly positive day, but not bad considering the profit taking that was going on early today.
TheTechTrader.com board showed mostly narrow-fractional gainers. Priceline.com (PCLN) was up 6.29 to 1350.51, Google Inc. (GOOG) up 4.49 to 742.09, Apple Inc. (AAPL) closed flat but positive by a penny at 105.91, while Amazon.com Inc. (AMZN) was up 1.90 to 553.98, and Netflix, Inc. (NFLX) closed flat, but down 6 cents to 101.06.
Baidu, Inc. (BIDU) was down 80 cents to 187.12, Facebook, Inc. (FB) closed up 40 cents to 111.85, and First Solar, Inc. (FSLR) dropped 1.20 to 71.24.
Tesla Motors, Inc. (TSLA) jumped 5.58 to 238.32.
Biotech’s were mixed, but somewhat firm today. Intrexon Corporation (XON), which was one of several gainers in this sector, ran to 39.49 before closing at 38.44, up 1.06.
Checking the TheTechTrader.com percent-gain leaderboard, Kitov Pharmaceuticals Holdings LTD (KTOV) gained 90 cents to 4.60, or 24%, on 2.5 million shares. Solazyme, Inc. (SZYM) climbed 47 cents to 2.73, or 21%, on 3.4 million shares.
Cara Therapeutics Inc. (CARA) advanced 1.10 to 6.27, or 21%, on 3.1 million shares traded. Advaxis, Inc. (ADXS) bounced 1.01 to 9.25, or 12%, on 1.8 million shares traded. Celator Pharmaceuticals, Inc. (CPXX) popped 1.01 to 9.71, or 12%, or 6.4%, on 6.4 million shares.
OvaScience, Inc. (OVAS) ran 1.84 to 10.58, 21%, on 1.7 million shares. Sarepta Therapeutics, Inc. (SRPT) jumped 3.71 to 21.71, or 21%, on 6.9 million shares. GW Pharmaceuticals (GWPH) bounced 8.15 to 80.87, or 11%.
The VelocityShares 3x Inv Natural Gas ETN (DGAZ) thrust 2.41 to 23.30, or 11.6%, on 4.15 million shares.
Among other gainers, Prothena Corporation (PRTA) was up 3.30 to 40.62, ACADIA Pharmaceuticals Inc. (ACAD) up 1.74 to 21.53, and Intra-Cellular Therapies, Inc. (ITCI) 1.99 to 26.15.
Stepping back and reviewing the hourly chart patterns, the indices were choppy, but higher until the last hour when they backed off, and then snapped back to finish normally positive on the day after a somewhat weak start in the morning.
Let’s see what happens tomorrow.
Good Trading!
In using any portion of The Technical Trader, you agree to the Terms and Conditions governing the use of the service as described in this disclaimer. Our disclaimers, policies and terms are subject to change without notice. The Technical Trader (www.thetechtrader.com) is published by Century-Pacific Investments and AdviceTrade, Inc., both of which are publishers. The Web site is maintained by Codexia, LLC. None of these firms, nor Mr. Boxer, is registered as a broker-dealer or investment adviser either with the U.S. Securities and Exchange Commission or with any state securities authority. Each trade mentioned in the diary and other sections of The Technical Trader is hypothetical and is not an actual trade. Mr. Boxer and employees of Century-Pacific, AdviceTrade and Codexia are not allowed to have personal positions in stocks mentioned in the diary and other sections of The Technical Trader. This policy, first announced to subscribers on June 2, 2004, gave Mr. Boxer a deadline that was extended to July 30, 2004 for liquidating any existing personal holdings in stocks mentioned on the site. Our holdings page, in which Mr. Boxer listed his personal positions in stocks mentioned on the site, was removed at that time. The publishers are not permitted to have any financial relationship with companies mentioned on the site. Mr. Boxer may recommend trades of stocks mentioned in the Diary as a consultant to hedge funds, but has agreed not to make such recommendations until after the stock has been posted on The Technical Trader Web site. Mr. Boxer's commentaries, trading ideas and model trades represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Neither we nor Mr. Boxer claim to have any non-public information regarding the companies mentioned in this site. The trade prices that appear on this Web site are based on the average of the real-time bid and real-time ask prices provided by Money.net, except when entered manually by Mr. Boxer should Money.net's feed be temporarily down. There may be a delay between the price as it appears in the diary and the current price that you see from your terminal due to delays in Internet connectivity, quote delays, refresh intervals in the case of the Web-based diary page, data entry errors, and market conditions, and also due to times when Mr. Boxer is not available to make the trade at the moment a previously stated target has been met. Entries may at times be in error due to system or data-entry errors. Hypothetical performance results do not include trading commissions and other execution costs that would be incurred if the trades referenced in the diary or elsewhere on the site were actual trades. Past performance is no guarantee of future results.
Recommended Content
Editors’ Picks
USD/JPY jumps above 156.00 on BoJ's steady policy
USD/JPY has come under intense buying pressure, surging past 156.00 after the Bank of Japan kept the key rate unchanged but tweaked its policy statement. The BoJ maintained its fiscal year 2024 and 2025 core inflation forecasts, disappointing the Japanese Yen buyers.
AUD/USD consolidates gains above 0.6500 after Australian PPI data
AUD/USD is consolidating gains above 0.6500 in Asian trading on Friday. The pair capitalizes on an annual increase in Australian PPI data. Meanwhile, a softer US Dollar and improving market mood also underpin the Aussie ahead of the US PCE inflation data.
Gold price flatlines as traders look to US PCE Price Index for some meaningful impetus
Gold price lacks any firm intraday direction and is influenced by a combination of diverging forces. The weaker US GDP print and a rise in US inflation benefit the metal amid subdued USD demand. Hawkish Fed expectations cap the upside as traders await the release of the US PCE Price Index.
Sei Price Prediction: SEI is in the zone of interest after a 10% leap
Sei price has been in recovery mode for almost ten days now, following a fall of almost 65% beginning in mid-March. While the SEI bulls continue to show strength, the uptrend could prove premature as massive bearish sentiment hovers above the altcoin’s price.
US economy: Slower growth with stronger inflation
The US Dollar strengthened, and stocks fell after statistical data from the US. The focus was on the preliminary estimate of GDP for the first quarter. Annualised quarterly growth came in at just 1.6%, down from the 2.5% and 3.4% previously forecast.